Johnson & Johnson Talc: Baby Powder, Asbestos Contamination & the Texas Two-Step Bankruptcy

Johnson & Johnson & the History of Talc-Based Baby Powder

Johnson & Johnson was founded in 1886 in New Brunswick, New Jersey, and rapidly became one of the most trusted names in American consumer healthcare. The company’s Baby Powder product — marketed under the Johnson’s brand — was introduced in the late nineteenth century and became one of the longest-running and most recognizable consumer products in U.S. history. For well over a century, Johnson’s Baby Powder was a household staple: recommended by pediatricians for diaper rash prevention, used by women for personal hygiene and perineal care, and applied as a general body powder by consumers of all ages. The product’s identity — its white color, fine particle size, mild scent, and smooth texture — was defined entirely by its active ingredient: cosmetic-grade talc, a naturally occurring mineral mined primarily in the United States, Canada, and Europe.

Talc’s defining characteristic as a cosmetic ingredient is its softness and its ability to absorb moisture. Mineralogically, talc is a hydrated magnesium silicate, and in its pure form it poses no identified health risk. The problem with Johnson’s Baby Powder was never pure talc — it was the asbestos contamination that occurred because the geological formations where cosmetic-grade talc is mined, particularly the deposits in Montana, Vermont, and other locations, also contain asbestos-bearing minerals. In the specific case of the talc deposits that supplied Johnson & Johnson for decades — principally through its primary supplier, originally Windsor Minerals, then Luzenac America, then Rio Tinto Minerals, and ultimately Imerys Talc America — the talc ore bodies contained tremolite asbestos, a naturally occurring amphibole mineral that, when present in cosmetic talc at any detectable level, introduces a carcinogenic hazard into a product applied daily to the human body.

Johnson & Johnson was not an innocent bystander who learned of the contamination problem after it emerged in litigation. Internal documents produced through court-ordered discovery in mesothelioma and ovarian cancer cases — and later described in detail by Reuters in a December 2018 investigative report and by the New York Times in subsequent coverage — showed that J&J scientists, executives, and regulatory affairs staff were aware of asbestos contamination findings in Baby Powder talc as far back as the 1970s. Test results showing the presence of asbestos in talc samples, internal memoranda discussing contamination findings, and company correspondence about regulatory strategy regarding asbestos testing methodology accumulated in J&J’s internal files over decades. The company fought with internal and external scientists over what testing methods should be used to detect asbestos in talc, in part because different methodologies produced different detection sensitivities — and J&J’s own experts at times advocated for less sensitive test methods that were less likely to detect contamination.

In addition to Baby Powder, Johnson & Johnson’s talc exposure liability extends to Shower to Shower, a body powder product originally developed for adult consumer use and marketed under the tagline “a sprinkle a day keeps odor away.” Shower to Shower was produced using talc from the same supply chain as Baby Powder, creating the same contamination risk for adult consumers who used the product on a daily or near-daily basis. J&J sold the Shower to Shower brand to Valeant Pharmaceuticals International in 2012, but the legacy liability for historical talc contamination in the product remained with J&J as the manufacturer and marketer during the relevant decades of consumer use. Both Baby Powder and Shower to Shower products remain at the center of active claims.

The scale of J&J’s talc litigation exposure is difficult to overstate. By the early 2020s, the company faced more than 38,000 lawsuits in the federal multidistrict litigation consolidated in New Jersey, along with thousands of additional cases in state courts. When all pending and potential future claims were aggregated, estimates of J&J’s total talc liability reached into the tens of billions of dollars. The combination of the evidentiary record from internal documents, the consistent pattern of plaintiff verdicts in cases that reached trial, and the sheer volume of mesothelioma and ovarian cancer diagnoses attributable to talc exposure made clear to J&J’s management and legal team that the conventional litigation path would be enormously expensive, risky, and potentially existential for the talc business unit. This calculation drove the decision to pursue an unconventional and legally aggressive bankruptcy strategy that had never been used at this scale for consumer product mass tort liability.

Products & Exposure Pathways

The J&J talc litigation is unique among asbestos mass torts because the primary exposure population consists overwhelmingly of consumers — not industrial workers. Women who used Johnson’s Baby Powder or Shower to Shower as a personal hygiene product, often daily for decades, form the largest group of claimants. The mechanism of exposure — applying fine powder to the body, generating an aerosol of talc particles in the immediate breathing zone, often in an enclosed bathroom — is fundamentally different from the high-dose occupational exposures that characterize most industrial asbestos cases, but can still produce cumulative exposures sufficient to cause mesothelioma and ovarian cancer over a multi-decade period of regular use.

The medical science connecting cosmetic talc use to mesothelioma and ovarian cancer has been established through multiple independent lines of evidence. Epidemiological studies of women with heavy long-term perineal talc use have consistently found elevated rates of both peritoneal mesothelioma and ovarian cancer compared to non-users. Pathological studies have detected talc particles and asbestos fibers in the ovarian tissue and peritoneal lymph nodes of affected women. Animal studies have demonstrated the biological plausibility of the migration pathway from perineal application to the reproductive tract. And the mass of trial verdicts — based on particularized evidence about contamination levels in specific product lots and medical expert testimony about causation mechanisms — has confirmed that courts and juries across the country find the evidence of causation sufficient to support liability judgments against Johnson & Johnson.

Who Was Exposed & Who Is Filing Claims

The single largest category of J&J talc claimants consists of women who used Johnson’s Baby Powder as a personal hygiene product — specifically, women who applied the powder to the perineal region on a daily or near-daily basis over extended periods. This pattern of use was actively encouraged by Johnson & Johnson’s own marketing materials for decades, and it was the most common use pattern among the women who subsequently developed peritoneal mesothelioma and ovarian cancer. These women typically used the product beginning in their teenage years or young adulthood and continued use for 20, 30, or 40 years — accumulating a total dose of talc exposure that, when contaminated with tremolite asbestos, was sufficient to trigger the carcinogenic process. The latency period between initial asbestos exposure and mesothelioma diagnosis typically ranges from 20 to 50 years, meaning women diagnosed today may have received their critical exposure dose in the 1970s or 1980s.

Caregivers who applied baby powder to infants and young children during diapering and bathing represent a second significant exposure population. These individuals — predominantly mothers and grandmothers, though fathers and professional caregivers are also represented — applied powder by shaking the container, which generated a visible talc aerosol in the immediate breathing zone of the caregiver. Repeated exposure of this type, often multiple times daily over the several years of a child’s diapering period, could produce cumulative inhalation doses comparable to those accumulated through personal use. Mesothelioma cases in this caregiver population have been successfully litigated, establishing that the baby powder application mechanism is a recognized and legally sufficient exposure pathway.

Cosmetic industry workers who regularly applied talc-based products professionally — makeup artists, salon workers, and beauty counter employees — faced occupational exposure from daily handling of talc-containing cosmetics. Although the individual exposure events were lower-dose than heavy industrial applications, the frequency and duration of professional cosmetic work could produce meaningful cumulative exposure to any asbestos fibers present in the cosmetic-grade talc base materials. Cases involving professional cosmetic workers have been included in the talc mass tort litigation and have proceeded to trial in several jurisdictions.

Factory workers at Johnson & Johnson production facilities where Baby Powder was filled and packaged represent an additional occupational exposure category. Workers on filling lines who handled bulk talc — shoveling, pouring, or otherwise manipulating large quantities of talc powder in production areas — could be exposed to higher ambient concentrations of talc dust, and any asbestos fibers present in the bulk talc supply would be proportionally concentrated in that occupational environment compared to the individual consumer use environment. These workers may have received occupational exposure through their employer regardless of whether they also used the consumer product personally.

The geographic distribution of J&J talc claimants is nationwide. Because Johnson’s Baby Powder and Shower to Shower were available in virtually every retail pharmacy, grocery store, and mass merchandise outlet across the United States for more than five decades, the exposure population is not concentrated in any particular industrial region, profession, or demographic group in the way that most industrial asbestos exposure populations are. The ubiquity of the product — and the long cultural tradition of baby powder use encouraged by J&J’s own advertising — is precisely what makes this the largest single consumer product mass tort in American legal history by number of claimants.

The Texas Two-Step: J&J’s Attempted Bankruptcy Escape & Its Rejection by Courts

Faced with what it described as an “unmanageable” litigation environment, Johnson & Johnson devised a legal strategy that had no precedent at the scale of the J&J talc litigation: the so-called Texas Two-Step. The maneuver exploits a provision of the Texas Business Organizations Code that allows a corporation to divide itself into two separate entities through a procedure called a divisional merger. In a divisional merger, one entity retains the operating assets and business value of the original company, while a second entity is created to assume specific liabilities — in J&J’s case, all talc-related personal injury claims. The liability-bearing entity is then immediately filed into Chapter 11 bankruptcy, activating the automatic stay that halts all pending litigation, while the parent company — with its assets safely sequestered in the “good company” entity — continues operating as normal, insulated from the litigation it has just orphaned into bankruptcy court.

Johnson & Johnson executed the first Texas Two-Step in October 2021. The company created a new subsidiary called LTL Management LLC, transferred to it all of Johnson & Johnson’s talc-related litigation liability, and then immediately caused LTL Management to file for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the Western District of North Carolina. The filing automatically stayed all pending talc litigation against LTL Management (and, J&J argued, against Johnson & Johnson itself as an affiliate). LTL Management had no employees, no operations, no products, and no assets beyond a funding agreement with Johnson & Johnson that provided access to funds necessary to resolve claims. It was, in essence, a litigation management vehicle designed to use bankruptcy court procedures to constrain and cap J&J’s talc liability, rather than a genuinely distressed business entity using bankruptcy to reorganize its affairs.

Plaintiffs’ attorneys, state attorneys general, and consumer advocates immediately challenged the LTL bankruptcy filing as an abuse of the bankruptcy process. They argued that the Texas Two-Step maneuver was not a legitimate use of Chapter 11 — which is designed for financially distressed debtors unable to pay their debts — because LTL Management was not financially distressed in any meaningful sense. LTL had immediate access to billions of dollars through the J&J funding agreement, and its parent company, Johnson & Johnson, was one of the largest and most financially robust corporations in the world with a market capitalization exceeding three hundred billion dollars. Using the bankruptcy process to halt litigation by a financially healthy company’s litigation spinoff, opponents argued, was precisely the kind of abuse the bankruptcy courts were not designed to accommodate.

The Third Circuit Court of Appeals agreed with the plaintiffs. In a landmark decision issued in January 2023 in In re LTL Management, LLC, a three-judge panel of the Third Circuit ruled that LTL Management’s Chapter 11 petition should be dismissed for lack of good faith. The court held that a debtor must be in genuine financial distress to qualify for Chapter 11 protection, and that LTL Management did not meet that standard because it had virtually unlimited access to J&J’s resources through the funding agreement. The opinion was a sweeping rebuke of the Texas Two-Step strategy as applied to LTL, and it was widely viewed as one of the most significant mass tort bankruptcy decisions in a generation. It restored the ability of talc claimants to pursue their cases in civil courts.

Rather than abandon the strategy, Johnson & Johnson immediately filed a second LTL Management bankruptcy petition, again in the bankruptcy court, in March 2023. The second LTL filing tried to address the Third Circuit’s good-faith holding by modifying the funding agreement structure in ways J&J argued eliminated the financial distress problem. Critics responded that the second filing was simply the same maneuver with cosmetic modifications, designed to run out the clock on plaintiffs who were seriously ill and dying while their cases were frozen in bankruptcy court. The second LTL petition was also dismissed in August 2023, with the bankruptcy court finding that J&J had still not demonstrated the genuine financial distress required for a valid Chapter 11 filing.

Undeterred by two consecutive dismissals, Johnson & Johnson restructured the effort a third time in 2024, this time under the name Red River Talc LLC — a new divisional spinoff that incorporated revised financial arrangements designed to overcome the judicial objections to the two prior LTL filings. Johnson & Johnson simultaneously announced a proposed settlement of approximately 6.475 billion dollars that it claimed would resolve all talc claims, contingent on the bankruptcy court accepting the Red River Talc filing and a supermajority of claimants voting to approve the plan. The settlement proposal was fiercely contested by plaintiffs’ attorneys, who argued that the settlement value was inadequate relative to the total value of claims, that the voting procedures were structured in ways that diluted the voice of the most seriously injured claimants, and that the continued use of a bankruptcy vehicle to resolve claims against a financially healthy parent corporation was improper as a matter of law. Courts again rejected the Red River Talc maneuver, and as of 2025, active mass tort litigation against Johnson & Johnson in the talc cases continues in federal and state courts.

The repeated failure of J&J’s bankruptcy strategies has significant practical implications for claimants. The litigation stays imposed by the LTL and Red River Talc bankruptcy filings delayed many cases for months or years — a devastating consequence for mesothelioma patients with a median survival of twelve to eighteen months from diagnosis, some of whom died before their cases could be resolved. With the bankruptcy maneuvers rejected and active litigation reinstated, claimants and their families can now pursue their cases in the civil court system, where the full evidentiary record — including the internal J&J documents showing corporate knowledge of asbestos contamination — can be presented to a jury.

What Internal Documents Revealed: J&J’s Knowledge of Contamination

The evidentiary record of Johnson & Johnson’s internal knowledge of talc contamination is one of the most extensive and damaging corporate document records in mass tort litigation history. The Reuters December 2018 investigative report titled “Johnson & Johnson Knew for Decades That Asbestos Lurked in Its Baby Powder” drew on thousands of pages of internal J&J documents, testing records, deposition transcripts, and scientific correspondence obtained through discovery in the talc litigation. The core findings were stark: J&J employees and contractors had found, on multiple occasions spanning several decades, that samples of the talc used in Baby Powder contained asbestos. The company responded not with product reformulation, consumer warnings, or regulatory disclosure, but with internal debates about testing methodologies, damage control strategies, and efforts to influence the scientific and regulatory standards being developed to govern asbestos testing in cosmetic talc.

Among the specific findings reported in investigative coverage and established through trial evidence: a 1972 internal memo from a J&J scientist described finding tremolite asbestos in talc samples; a 1976 internal document discussed concern about asbestos in the company’s consumer talc products; multiple internal test results from the 1970s and 1980s showed positive results for asbestos in talc samples; and internal correspondence among J&J employees and consultants showed active deliberation about how to respond to these findings in ways that minimized regulatory and litigation risk. Some internal documents revealed that J&J pushed back on federal regulatory proposals to require more sensitive testing methods for asbestos in cosmetic talc, a position that — if the more sensitive methods had been required — might have forced product reformulation or withdrawal years or decades earlier than the eventual voluntary discontinuation.

Johnson & Johnson has consistently and vigorously disputed the characterization of these documents, arguing that the vast majority of testing conducted on Baby Powder showed no asbestos, that the product met applicable safety standards, and that the investigative reporting presented an incomplete and misleading picture of the company’s internal knowledge and decision-making. The company has maintained that its Baby Powder was and is safe when used as directed. Those positions have been tested before juries in hundreds of trials across the country, and juries have frequently rejected them, returning verdicts for plaintiffs in mesothelioma and ovarian cancer cases based on the full evidentiary record. The judicial system’s refusal to accept J&J’s litigation narrative in the face of the internal documentary record is itself a significant part of the history of this litigation.

The U.S. Food and Drug Administration and other regulatory agencies have taken steps in response to the talc contamination evidence. In 2019, the FDA tested a sample of J&J Baby Powder and found asbestos contamination, prompting J&J to voluntarily recall that specific production lot. The FDA subsequently expanded its talc safety testing program. In 2022, the FDA proposed a rule that would require manufacturers of talc-containing cosmetics to test for and disclose asbestos contamination. These regulatory actions have added authoritative institutional weight to the evidence already present in the civil litigation record and have further undermined J&J’s public position that its Baby Powder was asbestos-free throughout its commercial history.

Current Legal Status & Filing a Claim in 2025

As of 2025, Johnson & Johnson faces active mass tort litigation in the talc cases in multiple venues. The federal multidistrict litigation in the District of New Jersey, where tens of thousands of federal talc cases were consolidated before Judge Michael Shipp, has been the primary federal forum for the litigation. State court litigation, including the multicounty litigation in New Jersey state court and individual cases in California, Missouri, and other states, continues to generate trial dockets. With the bankruptcy maneuvers rejected, cases that were stayed during the LTL and Red River Talc proceedings are being reinstated and moved toward trial. J&J has also continued to pursue individual case settlements, but without a comprehensive bankruptcy-structured resolution in place, litigation proceeds case by case.

Unlike most industrial asbestos defendants who have resolved their liability through bankruptcy trust mechanisms, Johnson & Johnson remains a financially robust, publicly traded corporation that is fully capable of paying judgments and settlements from its own operating resources. This distinction is critical for claimants: there is no trust fund to file against for J&J’s own talc liability. Claims against J&J must be pursued through the civil litigation system — either by filing an individual lawsuit, joining the existing MDL, or participating in a state court multicounty litigation docket. An experienced mass tort attorney handling talc cases will file your case in the appropriate jurisdiction, obtain access to the extensive existing discovery record including the damaging internal J&J documents, and pursue your case through the settlement or trial process.

For individuals who used Johnson’s Baby Powder or Shower to Shower and have been diagnosed with mesothelioma or ovarian cancer, or for family members of such individuals, the time to act is now. Mesothelioma cases carry statutes of limitation that vary by state — typically one to three years from the date of diagnosis or the date when the connection between the disease and talc exposure was discovered. Missing a statute of limitations deadline extinguishes the right to sue. Because J&J has actively used litigation delay tactics including the serial bankruptcy filings described above, claimants should not assume there is time to wait. Consulting with an experienced talc and mesothelioma attorney as early as possible after diagnosis is the single most important step a claimant can take to protect their legal rights and maximize their potential recovery.

Claimants who have both J&J talc claims and grounds to file against the Imerys Talc Personal Injury Trust should note that these are independent proceedings requiring separate legal actions. The Imerys Trust was created through Imerys’s own Chapter 11 bankruptcy and operates independently of J&J’s litigation. Filing a trust claim against Imerys and filing a lawsuit against Johnson & Johnson are not mutually exclusive, and a comprehensive legal strategy will pursue both. An experienced attorney in the talc litigation will identify every potentially responsible party in your exposure history and develop a coordinated strategy that pursues maximum compensation from every available source.

Frequently Asked Questions